Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.71 USD
+0.11 (6.56%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.74 +0.04 (2.05%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Income Statements
Fiscal Year end for Molecular Templates Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 57 | 20 | 39 | 19 | 22 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 57 | 20 | 39 | 19 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 68 | 109 | 119 | 120 | 93 |
Income After Depreciation & Amortization | -10 | -89 | -80 | -101 | -70 |
Non-Operating Income | 5 | 1 | 0 | -2 | 2 |
Interest Expense | 3 | 5 | 3 | 2 | 1 |
Pretax Income | -8 | -93 | -83 | -105 | -69 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -8 | -93 | -83 | -105 | -69 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -93 | -83 | -105 | -69 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | -80 | -73 | -96 | -69 |
Depreciation & Amortization (Cash Flow) | 7 | 9 | 7 | 4 | 2 |
Income After Depreciation & Amortization | -10 | -89 | -80 | -101 | -70 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 4.50 | 3.76 | 3.69 | 3.18 | 2.52 |
Diluted EPS Before Non-Recurring Items | -2.25 | -24.74 | -22.49 | -31.93 | -18.89 |
Diluted Net EPS (GAAP) | -1.80 | -24.74 | -22.49 | -32.98 | -27.89 |
Fiscal Year end for Molecular Templates Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7.02 | 6.80 | 6.87 | 36.63 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 7.02 | 6.80 | 6.87 | 36.63 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.39 | 11.93 | 18.61 | 24.84 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.37 | -5.13 | -11.74 | 11.79 |
Non-Operating Income | NA | 1.45 | 1.02 | 2.06 | 0.46 |
Interest Expense | NA | 0.04 | 0.03 | 1.19 | 1.40 |
Pretax Income | NA | -3.96 | -4.15 | -10.87 | 10.85 |
Income Taxes | NA | -0.01 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.95 | -4.15 | -10.87 | 10.85 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.95 | -4.15 | -10.87 | 10.85 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 5.37 | 5.09 | 3.76 | 3.76 |
Diluted EPS Before Non-Recurring Items | NA | -0.73 | -0.82 | -3.30 | 2.85 |
Diluted Net EPS (GAAP) | NA | -0.98 | -0.82 | -2.85 | 2.85 |